112 results about "Purpura haemorrhagica" patented technology

The invention relates to a medicament for treating allergic purpura, which is prepared from the following raw materials in portion by weight: 25-35 portions of astragalus root, 10-14 portions of radixscrophulariae, 18-22 portions of rehmanniae praeparatum, 18-22 portions of forsythia, 18-22 portions of rehmanniae vaporata, 9-11 portions of angelica, 18-22 portions of red paeonia, 7-9 portions ofcortex moutan, 18-22 portions of lithospermum, 14-16 portions of double blossom, 18-22 portions of agrimony, 5-7 portions of liquorice, 2-4 portions of safflower, 14-16 portions of salvia miltiorrhiza, 9-11 portions of sanguisorba, 9-11 portions of cattail pollen, 2-4 portions of rush, 9-11 portions of divaricate saposhnikovia root, 14-16 portions of rhizoma belamcandae, 14-16 portions of couchgrass root, 9-11 portions of medlar, 9-11 portions of indigowoad root and 9-11 portions of atractylodes macrocephala. The invention has the advantages of good curative effect, quick response, no toxic and side effects, low cost, convenient taking, treatment of both principal and secondary aspect of disease and no relapse, and can ensure that patients obtain good clinical effect after taking for 3-5 courses.

The invention relates to lithospermum oil and a preparation method thereof. The lithospermum oil is formed by lithospermum and sesame oil or rap oil according to the component ratio of 1 to 3, is prepared by the method of cleaning and chopping, mixing and soaking, waterproof cooking, aseptic filtration and storage for standby, solves the problem that no economic, applicable, convenient and effective Chinese medicine preparation is used for treating disposable diaper dermatitis of infants, does not need to be orally taken, is economic and convenient, has no adverse reaction and side effect, has ideal treatment effect, is currently the best Chinese medicine preparation for treating disposable diaper dermatitis of the infants, and is also suitable for treating diseases such as edema pain, pimple, tetter, dermatitis, exfoliative inflammation of lips, anaphylactoid purpura and so on.

The invention provides a medicament for treating allergic purpura, which is prepared from the following raw material medicaments in part by weight: 10 to 15 parts of Japanese thistle herb, 10 to 15 parts of common cephalanoplos herb, 5 to 10 parts of periostracum cicada, 10 to 15 parts of rehmannia root charcoal, 10 to 15 parts of baical skullcap root charcoal, 10 to 15 parts of garden burnet root charcoal,15 to 20 parts of lalang grass rhizome, 10 to 15 parts of the root bark of the peony tree, 10 to 15 parts of twotooth achyranthes root, 10 to 20 parts of poria, 15 to 20 parts of largehead atractylodes rhizome, 10 to 15 parts of red peony root, and 6 to 12 parts of raw liquorice. The raw material medicaments can be prepared into various conventional oral preparations by Chinese medicinal preparation conventional methods. The medicament has the functions of eliminating pathogenic heat from the blood, removing stasis to stop bleeding and resisting allergy, can treat both the symptoms and root causes of allergic purpura with perfect curative effect, and prevents relapse after healing. Clinical observation of 896 patients proves that the total effective rate of the medicament reaches 89.7 percent.

The invention is based on the discovery that GM-CSF antagonists can be used for the treatment of Idiopathic Thrombocytopenia Purpura (ITP). Accordingly, the invention provides methods of administering a GM-CSF antagonist, e.g., a GM-CSF antibody, to a patient that has ITP and pharmaceutical compositions comprising such antagonists.

The invention relates to a traditional Chinese medicine for treating allergic purpura, and the traditional Chinese medicine is composed of pharmaceutical raw materials with the following mixture ratio by weight: 0.5-0.8g of antelope horn powder, 20-25g of dried rehmannia root, 10-15g of sinkiang arnebia root, 10-15g of tree peony bark, 10-15g of red paeony root, 30-40g of lalang grass rhizome, 10-15g of India madder root, 30-40g of hairyvein agrimonia herb and bud, 10-15g of fineleaf schizonepeta herb, 10-15g of cicada slough, 30-40g of raw gypsum, 6-9g of stir-fried common anemarrhena rhizome, 6-9g of stir-fried cape jasmine fruit, 12-15g of gambir plant, 3-5g of stewed rhubarb and 6-9g of raw liquoric root. The traditional Chinese medicine has simple prepration, low cost, wide range of medicine sources, convenient use, rapid efficacy, high cure rate and no toxicity or side effects; the effective rate is 95 percent and the cure rate is 80 percent after the years of clinical applications.

A formulation for a stable ascorbic acid composition which, in a simplified form, is comprised of ascorbic acid in solution with a hygroscopic compound (i.e., a substance with the ability to attract water molecules from the surrounding environment through either absorption or adsorption). Also disclosed herein are methods for the production of such compounds and methods of using such compounds in the prevention, inhibition and treatment of striae gravidarum, radiation dermatitis, rhytids, lentigoes, dyschromia, sun-damage induced hyperpigmentation, cellulite, scars and purpura, among other skin diseases or conditions.

The invention belongs to the technical field of medicines, and discloses a traditional Chinese medicine composition for treating anaphylactoid purpura. The traditional Chinese medicine composition is prepared from the following components: honeysuckle stem, densefruit pittany root-bark, indigowoad leaf, natural indigo, radix sophorae flavescentis, cortex moutan, panax notoginseng and radix gentianae macrophyllae, and can be prepared into granules, capsules or tablets. The invention further discloses a preparation method for the granules, capsules and tablets of the traditional Chinese medicine composition. The traditional Chinese medicine composition has remarkable efficacies of clearing heat to remove toxicity, cooling blood to remove ecchymosis, and removing stasis to relieve pain, serves as an effective medicine for treating anaphylactoid purpura, particularly wind-heat anaphylactoid purpura, is little in side effect and high in safety.

The invention provides a soybean hot spicy sauce and a manufacturing method thereof. The soybean hot spicy sauce is prepared from the following raw materials according to the proportioning by weight: 5 of soybean, 1 of dried eggplant strips, 1 of cayenne pepper and 1.5 of salt and also comprises ginger powder and garlic powder which are used as seasoning accessories. After the soybean is boiled and fermented, the dried eggplant strips, the cayenne pepper, the salt and the seasoning accessories are added, and the mixture is uniformly mixed and stirred to prepare the soybean hot spicy sauce. Even though the varieties of the raw materials are few, the dried eggplant strips are used and the reasonable accessories are added so as to ensure that the taste of the soybean hot spicy sauce is quite delicious. The soybean hot spicy sauce has convenient manufacture, short production period, convenient operation process and proper salty and spicy taste. The eggplant has abundant nutrition and contains various nutritional ingredients such as protein, fat, carbohydrate, vitamins, calcium, phosphorus and ferrum and particularly, higher content of the vitamin P so as to have an incomparable advantage over other vegetables and fruits. The soybean hot spicy sauce with the dried eggplant contributes to preventing and treating hyperpiesis, coronary heart diseases, arteriosclerosis and purpura haemorrhagica and is particularly suitable for most people to eat.

The invention discloses an oral administration pharmaceutical composition for treating allergic purpura, wherein the active constituents include the following raw material herbs (by weight portion): agkistrodon acutus 16g, rhizome of Sichuan lovage 12g, Chinese angelica root 12g, dried rehmannia root 16g, cicada shell 3g, root of red rooted saliva 16g, root bark of tree peony 12g, cogongrass rhizome 15g, alkanna tinctoria 10g, plaster stone 3g and licorice root 5g. The medicament should be decocted in water for the oral dose.

The invention discloses a medicine used for treating allergic purpura. Medicines, such as astragalus mongholicus, ginseng, rhizoma atractylodis macrocephalae, angelica sinensis, radix rehmanniae, the root of red-rooted salvia, cortex moutan, scutellaria baicalensis, schisandra chinensis, smoked plum, hairyvein agrimony, lithospermum, rhizoma imperatae, eclipta alba, caulis spatholobi, madder and divaricate saposhnikovia root are smashed into powder, and then the powder is prepared into powder preparation to be orally taken. The medicine disclosed by the invention has the efficacy on tonifying spleen, tonifying qi, clearing heat, cooling blood, promoting circulation and removing stasis, and has the advantages of high cure rate for treating the allergic purpura, low recurrence rate, small toxic and side effect and no harm to liver or kidney, and the total effective rate is 99% by clinic observation.

The present invention features noninvasive methods for diagnosing IgA or IgM kidney disorders, such as IgA nephropathy, Henoch-Schönlein purpura, and IgM nephropathy, in a mammal. The invention also features compositions and kits useful in diagnosing these disorders.

A traditional Chinese medicine composition for treating henoch-schonleinpurpura relates to the technical field of Chinese herbal medicines, and is a medicament prepared from the following raw materials in part by weight: 28-32 parts of coptis, 28-32 parts of cape jasmine, 28-32 parts of radix scutellariae, 33-37 parts of ciliatenerve knotweed root, 18-22 parts of anemarrhena, 28-32 parts of radix astragali, 38-42 parts of Chinese yam, 28-32 parts of poriacocos, 33-37 parts of bighead atractylodes rhizome, 38-42 parts of Chinese angelica, 40-52 parts of raw rehmannia root, 38-42 parts of radix paeoniae alba, 23-27 parts of peach seeds, 23-27 parts of celosia cristata, 23-27 parts of sophora flower, 48-52 parts of euryaleferoxsalisb, 18-22 parts of garden burnet, 28-32 parts of jujube kernel, 28-32 parts of lithospermum, 33-37 parts of madder, 38-42 parts of radix curcumae, 28-32 parts of cortex moutan, 38-42 parts of ligusticumwallichii, 63-67 parts of polygala root and 58-62 parts of radix codonopsis. The traditional Chinese medicine composition is accord with traditional Chinese medicine syndrome differentiation theory on traditional Chinese medicinal material selection and compatibility; and the traditional Chinese medicine composition has the advantages of simple preparation method, fast effectiveness, high cure rate, uneasiness in recurrence and the like.

The present invention discloses a Chinese medicine for curing allergic purpura. Said Chinese medicine has the functions of clearing away heat, removing toxic material, removing heat from the blood and removing ecchymoses, and can obtain obvious therapeutic effect. Said Chinese medicine is made up by using 8 Chinese medicinal materials of krait/agkistrodon, ligusticum root, Chinese angelica root, dried/fresh rehmannia root, cicada molting, salvia root, moutan root bark and imperata root.

The invention relates to a traditional Chinese medicine (TCM) composition for treating allergic purpura. The composition is prepared from the following active pharmaceutical ingredients in parts by weight: 22-28 parts of cogon grass rhizome, 22-28 parts of lithospermum erythrorhizon, 22-28 parts of spreading hedyotis herb, 22-28 parts of radix rehmanniae, 22-28 parts of giant knotweed rhizome, 16-20 parts of radix astragali, 16-20 parts of flos sophorae, 16-20 parts of motherwort herb, 9-15 parts of radix paeoniae rubra, 9-15 parts of liquorice, 9-15 parts of hirsute shiny bugleweed herb, 9-15 parts of weeping forsythia capsule, 9-15 parts of divaricate saposhnikovia root, 9-15 parts of tree peony root bark, 9-15 parts of peach kernels, 9-15 parts of talcum and 9-15 parts of India madder root. The composition has the advantages of stable curative effects and no side effects.

The present invention relates to a traditional Chinese drug composition for treating anaphylactoid purpura. The traditional Chinese drug composition comprises the following traditional Chinese drug raw materials, wherein the traditional Chinese drug raw materials comprise, by weight, 5-20 parts of mongolian milkvetch root, 5-15 parts of cassiabarktree twig, 5-20 parts of white peony root, 2-10 parts of prepared liauorice root, 5-20 parts of redroot gromwell, 5-20 parts of imperatae rhizome, 5-20 parts of hairyvein agrimonia herb, 2-10 parts of black cicada slough, 5-15 parts of common ducksmeat herb, 2-10 parts of common jujube, and 5-15 parts of pagodatree flower bud. The traditional Chinese drug composition of the present invention has effects of heat clearing and detoxicating, blood cooling and blood stasis dissipating, liver fire clearing and pathogenic fire reducing, yang enhancing and qi activating, qi benefiting, and artery and vein recovering, and provides a significant therapeutic effect for the anaphylactoid purpura. The treatment effect is reliable. The traditional Chinese drug composition has characteristics of wide sources of the drug components, simple preparation, mild medicine property, and no toxic and side-effect.

The invention discloses an oral administration pharmaceutical composition for treating allergic purpura, wherein the active constituents include the following raw material herbs (by weight portion): honeysuckle flower 10g, capsule of weeping forsythia 10g, alkanna tinctoria 10g, root bark of tree peony 10g, root of red rooted saliva 6g, dried rehmannia root 8g, cogongrass rhizome 10g, dragon's blood resin 10g, red phaseolus bean 20g. The medicament should be decocted in water for the oral dose.

The invention relates to a traditional Chinese medicine composition for treating purpura. The medicine is composed of the following Chinese medicinal materials, by weight: 10-40 parts of dried rhizome of rehmannia, 10-40 parts of Herba Cirsii, 10-40 parts of hairyvein agrimony, 5-20 parts of gardenia, 10-40 parts of Eclipta alba, 10-40 parts of rhizoma nelumbinis, 10-30 parts of rhizoma anemarrhenae, 5-25 parts of Radix Scrophulariae, 5-20 parts of moutan bark, 10-30 parts of lithospermum erythrorhizon, 10-40 parts of dandelion, 5-20 parts of lophatherum gracile, 10-40 parts of Rhizoma imperatae, 5-25 parts of Ophiopogon, and 5-20 parts of golden cypress. The traditional Chinese medicine composition provided by the invention has efficacies of clearing heat, moisturizing dampness, discharging fire, detoxifying, cooling blood to stop bleeding, nourishing yin, promoting the secretion of saliva, promoting blood circulation and removing blood stasis, obvious curative effect on purpura and reliable effects; and the components have wide medicine source, simple preparation and no toxic or side effect.

The present invention is a Chinese traditional medicine combination for treating cold-deficiency purpura; the invention consists of following components: 25 to 50g of astragalus, 25 to 50g of radix codonopsiti, 20 to 30g of angelica, 20 to 30g of Salvia miltiorrhiza, 20 to 30g of old arable soil, 5 to 10g of hemlock parsley, 10 to 20g of radix raeoniae alba, 10 to 20g of atractylodes, 10 to 20g of Tuckahoe, 10 to 20g of donkeyhide glue, 5 to 10g of Radix Glycyrrhizae Preparata, 5 to 10g of cinnamon and 5 to 10g of aconite root. The invention is mainly applied to treatment of cold-deficiency purpura. The invention enriches blood, replenishes Qi and avoids harms from splenotomy, hormone and bacteriophage on human body.

The invention discloses a traditional Chinese medicine for treating anaphylactoid purpura, which is prepared from raw materials of dandelion, herba cepbalanoplosis segeti, root of rehmannia, Lonicera chrysantha flower, cortex moutan, bighead atractylodes rhizome, Twotooth Achyranthes Root, Poria cocos and pawpaw. The invention has the advantages of good and definite treatment effect and high effective rate of more than 78%.

The invention discloses a medicament used for treating allergic purpura. The medicament is prepared from gen-seng, largehead atractylodes rhizome, radix astragali, fructus jujubae, Chinese angelica, radix glycyrrhizae and longan according to a certain weight ratio. The medicament can be made into any common oral administration preparation. The medicament has functions of tonifying qi and spleen, nourishing blood and promoting blood circulation, cooling blood and removing toxic and regulating immunity. The medicament can be used for treating the allergic purpura with advantages of rapid effect, high cure rate and no recurrence.

The thrombocytopenia treating Chinese medicine is orally taken preparation prepared with Chinese medicinal materials including notoginseng, bletilla tuber, cogongrass rhizome, and lotus root charcoal. Clinical test shows that the Chinese medicine of the present invention has obvious thrombocyte increasing and clinical symptom remitting effect on light and medium thrombocytopenia, including primary thrombocytopenia purpura caused by some medicine and has no toxic side effect. On serious thrombocytopenia, the present invention may assist chemical medicine treatment and reduce toxic side effect.

The invention discloses a traditional Chinese medicine for treating wind heat type anaphylactoid purpura. The traditional Chinese medicine is prepared from, by weight, 15-30 parts of honeysuckle stems, 6-10 parts of herba schizonepetae, 6-10 parts of saposhnicovia divaricata, 9-12 parts of caulis pipers futokadsurae, 6-10 parts of radix cynanchi panicullati, 10-15 parts of salviae miltiorrhizae, 6-10 parts of radix rubiae and 6 parts of honey-fried licorice roots. Accordingly, the traditional Chinese medicine mainly dispels wind, clears away heat and promotes blood circulation to remove meridian obstruction, compatibility is ingenious, the effects of adjusting immune and preventing allergy are achieved, the curative effect is exact, relapse is not prone to occurrence, few side effects exist, and safety and convenience are achieved.

The present invention is a Chinese traditional medicine combination for treating blood-heat purpura. The invention consists of the following components: 5 to 10 shares of honeysuckle, 3 to 8 shares of Salvia miltiorrhiza, 4 to 7 shares of radix rehmanniae, 4 to 7 shares of eclipta prostrate, 5 to 8 shares of lithospermum, 3 to 7 shares of pasqueflower and 3 to 5 shares of liquorice. The invention is mainly applied to treatment of blood-heat purpura.

The invention relates to a medicament for treating anaphylactoid purpura, which is characterized by being prepared from the following raw materials in part by weight: 5 to 10 parts of weeping forsythia, 10 to 30 parts of fineleaf schizonepeta herb, 10 to 30 parts of Sinkiang arnebia root, 10 to 30 parts of red paeony root, 5 to 10 parts of garden burnet root, 5 to 15 parts of liquoric root, 10 to 30 parts of hairyvein agrimonia herb and 5 to 20 parts of safflower. The invention has the advantage that the medicament is prepared from common Chinese herbal medicines on the basis of the conventional theory of traditional Chinese medicine, and has the effects of clearing heat and detoxicating, dispelling wind and relieving exterior syndrome and cooling blood and promoting blood circulation; and in a formula, weeping forsythia is used for clearing heat and detoxicating, fineleaf schizonepeta herb is used for dispelling wind and relieving exterior syndrome, Sinkiang arnebia root is used for clearing heat and cooling blood, garden burnet root is used for cooling blood and stopping bleeding, hairyvein agrimonia herb is used for astringing to arrest bleeding, safflower is used for promoting blood circulation and dispelling stasis, red paeony root is used for stopping bleeding and dispelling stasis, and liquoric root is used for harmonizing the medicaments. The medicament has the good effects of purpura caused by injury of blood collaterals by heat, obstruction of collaterals by blood stasis, exogenous wind-heat evil and internal invading into blood vessels, can reduce the recurrence rate effectively and does not have toxic or side effect.